National Institute of Biomedical Imaging and Bioengineering; Notice of Meeting, 14175 [2010-6436]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 56 / Wednesday, March 24, 2010 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Advisory Council on Blood Stem Cell
Transplantation; Notice of Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), notice is hereby given
of the following meeting:
srobinson on DSKHWCL6B1PROD with NOTICES
Name: Advisory Council on Blood Stem
Cell Transplantation.
Date and Times: May 5, 2010, 8:30 a.m. to
4:30 p.m.
Place: Bethesda North Marriott Hotel and
Conference Center, 5701 Marinelli Road,
Bethesda, Maryland 20852.
Status: The meeting will be open to the
public.
Purpose: Pursuant to Public Law 109–129,
42 U.S.C. 274k (section 379 of the Public
Health Service Act, as amended) the ACBSCT
advises the Secretary of HHS and the
Administrator, HRSA, on matters related to
the activities of the C.W. Bill Young Cell
Transplantation Program (Program) and the
National Cord Blood Inventory (NCBI)
Program. ACBSCT is composed of up to 25
members, including the Chair, serving as
Special Government Employees. The current
membership includes representatives of
marrow donor centers and marrow transplant
centers; representatives of cord blood banks
and participating birthing hospitals;
recipients of a bone marrow transplant;
recipients of a cord blood transplant; persons
who require such transplants; family
members of such a recipient or family
members of a patient who has requested the
assistance of the Program in searching for an
unrelated donor of bone marrow or cord
blood; persons with expertise in bone
marrow and cord blood transplantation;
persons with expertise in typing, matching,
and transplant outcome data analysis;
persons with expertise in the social sciences;
basic scientists with expertise in the biology
of adult stem cells; ethicists; hematology and
transfusion medicine researchers with
expertise in adult blood stem cells; persons
with expertise in cord blood processing; and
members of the general public.
Agenda
The Council will hear reports from three
ACBSCT Work Groups: Access to
Transplantation, Cord Blood Collections, and
Scientific Factors Necessary To Define a Cord
Blood Unit as High Quality. The Council also
will hear presentations and discussions on
the following topics: Performance measures
and targets for programs, FDA final guidance
for cord blood licensure, models predicting
the impact of growth of the cord blood
inventory and the adult donor registry,
realizing the full potential of cord blood,
financial incentives for adult donors, and the
capacity of the national system to handle a
larger number of transplants. Agenda items
are subject to change as priorities indicate.
After the presentations and Council
discussions, members of the public will have
VerDate Nov<24>2008
16:24 Mar 23, 2010
Jkt 220001
an opportunity to provide comments.
Because of the Council’s full agenda and the
timeframe in which to cover the agenda
topics, public comment will be limited. All
public comments will be included in the
record of the ACBSCT meeting. Meeting
summary notes will be made available on the
HRSA’s Program Web site at https://
bloodcell.transplant.hrsa.gov/ABOUT/
Advisory_Council/.
The draft meeting agenda and a registration
form are available on the HRSA’s Program
Web site at https://
bloodcell.transplant.hrsa.gov/ABOUT/
Advisory_Council/.
Registration can also be completed
electronically at https://www.ACBSCT.com or
submitted by facsimile to Lux Consulting
Group, Inc., the logistical support contractor
for the meeting, at fax number (301) 585–
7741, ATTN: Tristan Alexander. Individuals
without access to the Internet who wish to
register may call Tristan Alexander at (301)
585–1261.
For Further Information Contact:
Remy Aronoff, Executive Secretary,
Healthcare Systems Bureau, Health
Resources and Services Administration,
5600 Fishers Lane, Room 12–105,
Rockville, Maryland 20857; telephone
(301) 443–3264.
Dated: March 16, 2010.
Sahira Rafiullah,
Director, Division of Policy and Information
Coordination.
[FR Doc. 2010–6438 Filed 3–23–10; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Meeting
14175
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council for Biomedical Imaging and
Bioengineering; NACBIB, May, 2010.
Date: May 21, 2010.
Open: 8:30 a.m. to 12:15 p.m.
Agenda: Report from the Institute Director,
other Institute Staff and presentations of
working group reports.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Independence Room
(2nd Level), Bethesda, MD 20817.
Closed: 1:30 p.m. to 3 p.m.
Agenda: To review and evaluate grant
applications and/or proposals.
Place: Bethesda Marriott Suites, 6711
Democracy Boulevard, Independence Room
(2nd Level), Bethesda, MD 20817.
Contact Person: Anthony Demsey, PhD,
Director, National Institute of Biomedical
Imaging, and Bioengineering, 6701
Democracy Boulevard, Room 241, Bethesda,
MD 20892.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the
Institute’s/Center’s home page: https://
www.nibib1.nih.gov/about/NACBIB/
NACBIB.htm, where an agenda and any
additional information for the meeting will
be posted when available.
Dated: March 17, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–6436 Filed 3–23–10; 8:45 am]
BILLING CODE 4140–01–P
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Council for
Biomedical Imaging and Bioengineering.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Drug Abuse;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The contract proposals and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
E:\FR\FM\24MRN1.SGM
24MRN1
]]>Agencies
[Federal Register Volume 75, Number 56 (Wednesday, March 24, 2010)]
[Notices]
[Page 14175]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-6436]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical Imaging and Bioengineering;
Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Advisory Council for Biomedical Imaging and Bioengineering.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and/or contract proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council for Biomedical
Imaging and Bioengineering; NACBIB, May, 2010.
Date: May 21, 2010.
Open: 8:30 a.m. to 12:15 p.m.
Agenda: Report from the Institute Director, other Institute
Staff and presentations of working group reports.
Place: Bethesda Marriott Suites, 6711 Democracy Boulevard,
Independence Room (2nd Level), Bethesda, MD 20817.
Closed: 1:30 p.m. to 3 p.m.
Agenda: To review and evaluate grant applications and/or
proposals.
Place: Bethesda Marriott Suites, 6711 Democracy Boulevard,
Independence Room (2nd Level), Bethesda, MD 20817.
Contact Person: Anthony Demsey, PhD, Director, National
Institute of Biomedical Imaging, and Bioengineering, 6701 Democracy
Boulevard, Room 241, Bethesda, MD 20892.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: https://www.nibib1.nih.gov/about/NACBIB/NACBIB.htm, where an
agenda and any additional information for the meeting will be posted
when available.
Dated: March 17, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-6436 Filed 3-23-10; 8:45 am]
BILLING CODE 4140-01-P
